DAVID DOBKIN

David Dobkin joined Boustead Securities in 2016 and brings over 20 years experience in investment banking, advisory and capital formation strategies.

 

Having lived and worked in China, Thailand, Dubai, Auckland, Los Angeles, New York and France, David brings strategic advisory and execution capability to his clients.  David has experience with Regulation A+ securities and capital formation for early stage companies and regularly speaks about raising capital. 

 

Prior to founding joining Boustead, David worked with the New Zealand Government facilitating capital formation on behalf of New Zealand companies and government agencies.  Most recently, David was the Regional Investment Director for the New Zealand government based in Dubai. David opened the Dubai investment office to better align New Zealand with Middle East investment with the goal of securing strategic foreign direct investment. 

Prior to arriving in Dubai, David Dobkin ran the Emirates Team New Zealand America’s Cup Investment leveraging activities in San Francisco, culminating in an investor showcase for Silicon Valley venture capital and private equity investors. He has been secured investment for New Zealand companies in the Healthcare, High Value Manufacturing, Aerospace and IT sectors, including establishing the $40mm Valar Early Stage Fund, run by Peter Thiel and Proliant’s $100mm Bovine Plasma greenfield investment. 

Prior to working for New Zealand in October 2010, David worked for Lazard Frères, where he facilitated and advised on cross-border mergers and acquisitions transactions in excess of $3 billion for Nike, Lockheed Martin, Quiksilver, Wynn Resorts, Morgans Hotels, Arrow International, CBS, Cryocore, Gyrocam Systems and others. David was also an investment banker in the Healthcare group for Wasserstein Perella in New York. He has founded, advised and led several start-up companies, including Aegix Performance Apparel, revitaPOP and DealProvider.com. David received a Master of Science, Biomedical Engineering, from the University of Southern California and Bachelor of Science, Biomedical Engineering, from Columbia University.

Holds FINRA Series 63, 79, and 83 security licenses.